Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTOR | P42345 | 6/20 | 0.43 |
| ▸ | PIK3CA | P42336 | 5/20 | 0.43 |
| ▸ | ALOX5AP | P20292 | 2/20 | 0.39 |
| ▸ | FEN1 | P39748 | 2/20 | 0.39 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.38 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.38 |
| ▸ | GPR119 | Q8TDV5 | 3/20 | 0.38 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.38 |
| ▸ | LIPE | Q05469 | 1/20 | 0.38 |
| ▸ | WDR5 | P61964 | 3/20 | 0.37 |
| ▸ | SCN9A | Q15858 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18848898 | 0.94 | MTOR (0.43) | MTORPIK3CAALOX5APFEN1HCRTR1 | |
| SCHEMBL21043258 | 0.94 | MTOR (0.43) | MTORPIK3CAALOX5APFEN1HCRTR1 | |
| SCHEMBL15539820 | 0.92 | MTOR (0.43) | MTORPIK3CAALOX5APFEN1HCRTR1 | |
| SCHEMBL15539262 | 0.92 | MTOR (0.43) | MTORPIK3CAALOX5APFEN1HCRTR1 | |
| SCHEMBL15539265 | 0.92 | MTOR (0.43) | MTORPIK3CAALOX5APFEN1HCRTR1 | |
| SCHEMBL21043182 | 0.91 | MTOR (0.42) | MTORPIK3CAALOX5APFEN1HCRTR1 | |
| SCHEMBL18849015 | 0.91 | MTOR (0.42) | MTORPIK3CAALOX5APFEN1HCRTR1 | |
| SCHEMBL18849078 | 0.90 | HCRTR1 (0.40) | MTORPIK3CAHCRTR1HCRTR2GPR119 | |
| SCHEMBL15539839 | 0.89 | PIK3CA (0.45) | MTORPIK3CAALOX5APFEN1HCRTR1 | |
| SCHEMBL15538344 | 0.89 | PIK3CA (0.45) | MTORPIK3CAALOX5APFEN1HCRTR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9776987-B2 | Amide derivatives for GPR119 agonist | CHONG KUN DANG PHARMACEUTICAL CORP (KR) | 2017-10-03 | — | — | US | disclosed |
| US-20170129875-A1 | AMIDE DERIVATIVES FOR GPR119 AGONIST | CHONG KUN DANG PHARMACEUTICAL CORP. (KR) | 2017-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170129875-A1 | AMIDE DERIVATIVES FOR GPR119 AGONIST | GPR119, FFAR2, GLP1R | MTOR 2407/4885PIK3CA 2212/4885ALOX5AP 1031/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.